资讯

Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic ...
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...
Texas Public Radio4 天
A non-opioid painkiller has hit the market, and a San Antonio doctor calls it a game-changer
UT Health San Antonio Multispecialty and Research Hospital is the first hospital in Texas to approve a non-narcotic ...
Drug Store News4 天
Azurity Pharmaceuticals obtains FDA OK for Xifyrm
Xifyrm is indicated for use in adults for the management of moderate-to-severe pain, alone or in combination with non-NSAID analgesics.
TMCnet4 天
Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient's Journey to Pain ...
Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the debut of a powerful new ...
MPR6 天
Xifyrm Approved for Management of Moderate to Severe Pain
The Food and Drug Administration (FDA) has approved Xifyrm ™ (meloxicam injection) for use in adults for the management of moderate to severe pain, alone or in combination with non-NSAID ...